149 related articles for article (PubMed ID: 16895176)
21. [Bosentan].
Taéron C
Rev Infirm; 2005 Feb; (108):33-4. PubMed ID: 15816717
[No Abstract] [Full Text] [Related]
22. [Discovery of endothelin and its significance].
Goto K
Nihon Rinsho; 2004 Sep; 62 Suppl 9():575-83. PubMed ID: 15506451
[No Abstract] [Full Text] [Related]
23. [Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
MMW Fortschr Med; 2002 Oct; 144(42):64. PubMed ID: 12534004
[No Abstract] [Full Text] [Related]
24. Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonist.
Losito A; Pittavini L; Covarelli C
Clin Nephrol; 2012 Feb; 77(2):164-70. PubMed ID: 22257549
[TBL] [Abstract][Full Text] [Related]
25. The endothelin system and its role in pulmonary arterial hypertension (PAH).
Pepke-Zaba J; Morrell NW
Thorax; 2005 Jun; 60(6):443-4. PubMed ID: 15923241
[No Abstract] [Full Text] [Related]
26. [Dyspnea. When is it pulmonary hypertension?].
MMW Fortschr Med; 2003 Aug; 145(33-34):62. PubMed ID: 14526588
[No Abstract] [Full Text] [Related]
27. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
Pullamsetti SS; Schermuly RT
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
[TBL] [Abstract][Full Text] [Related]
28. Endothelin XII.
Barton M; Yanagisawa M; Vanhoutte PM; Masaki T
Life Sci; 2012 Oct; 91(13-14):449-51. PubMed ID: 22842029
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.
Nakwan N; Choksuchat D; Saksawad R; Thammachote P; Nakwan N
Acta Paediatr; 2009 Oct; 98(10):1683-5. PubMed ID: 19523174
[TBL] [Abstract][Full Text] [Related]
30. Bosentan.
Mathier MA; Ishizawar D
Expert Opin Pharmacother; 2010 Apr; 11(6):1023-34. PubMed ID: 20307226
[TBL] [Abstract][Full Text] [Related]
31. Endothelin and endothelin receptor antagonism in portopulmonary hypertension.
Neuhofer W; Gülberg V; Gerbes AL
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():54-61. PubMed ID: 16919012
[TBL] [Abstract][Full Text] [Related]
32. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
[TBL] [Abstract][Full Text] [Related]
33. [Endothelin].
Kanno K; Hirata Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():581-4. PubMed ID: 16149582
[No Abstract] [Full Text] [Related]
34. Treatment of pulmonary arterial hypertension: a step forward.
Sharma S
Chest; 2003 Jul; 124(1):8-11. PubMed ID: 12853493
[No Abstract] [Full Text] [Related]
35. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
Raja SG
Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
[TBL] [Abstract][Full Text] [Related]
36. Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.
Miyagawa K; Emoto N
Ther Adv Cardiovasc Dis; 2014 Oct; 8(5):202-16. PubMed ID: 24990369
[TBL] [Abstract][Full Text] [Related]
37. Endothelin: from molecule to man.
Webb DJ
Br J Clin Pharmacol; 1997 Jul; 44(1):9-20. PubMed ID: 9241091
[No Abstract] [Full Text] [Related]
38. [Course of pulmonary artery hypertension disease].
Hoeper MM
Krankenpfl J; 2005; 43(4-6):113. PubMed ID: 16171059
[No Abstract] [Full Text] [Related]
39. Endothelins and pulmonary hypertension, what directions for the near future?
Eddahibi S; Adnot S
Eur Respir J; 2001 Jul; 18(1):1-4. PubMed ID: 11510778
[No Abstract] [Full Text] [Related]
40. [Current aspects of the role of endothelins in cardiac pathology].
Rossi G
Recenti Prog Med; 1997; 88(7-8):301-2. PubMed ID: 9324697
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
